SCHEMBL372979

SCHEMBL372979

CCCCCCCCCC[N+]1(C)CCCCC1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 4/20 0.50
APOBEC3A P31941 2/20 0.50
APOBEC3G Q9HC16 2/20 0.50
KMT2A Q03164 1/20 0.50
GNAI3 P08754 1/20 0.50
GNAO1 P09471 1/20 0.50
GNAI1 P63096 1/20 0.50
BBOX1 O75936 2/20 0.47
TSHR P16473 2/20 0.46
CYP3A4 P08684 1/20 0.46
TDP1 Q9NUW8 1/20 0.46
BLM P54132 1/20 0.46
PMP22 Q01453 1/20 0.46
KDM4E B2RXH2 1/20 0.45
CTDSP1 Q9GZU7 1/20 0.41
CHRM2 P08172 1/20 0.39
CHRM4 P08173 1/20 0.39
CHRM5 P08912 1/20 0.39
CHRM1 P11229 1/20 0.39
CHRM3 P20309 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14876680 1.00 LMNA (0.50) LMNAAPOBEC3AAPOBEC3GKMT2AGNAI3
SCHEMBL372728 1.00 LMNA (0.50) LMNAAPOBEC3AAPOBEC3GKMT2AGNAI3
SCHEMBL1270131 1.00 LMNA (0.50) LMNAAPOBEC3AAPOBEC3GKMT2AGNAI3
SCHEMBL17833010 1.00 LMNA (0.50) LMNAAPOBEC3AAPOBEC3GKMT2AGNAI3
SCHEMBL3767420 1.00 LMNA (0.50) LMNAAPOBEC3AAPOBEC3GKMT2AGNAI3
SCHEMBL2859790 1.00 LMNA (0.50) LMNAAPOBEC3AAPOBEC3GKMT2AGNAI3
SCHEMBL92719 1.00 LMNA (0.50) LMNAAPOBEC3AAPOBEC3GKMT2AGNAI3
SCHEMBL17832883 1.00 LMNA (0.50) LMNAAPOBEC3AAPOBEC3GKMT2AGNAI3
SCHEMBL3765758 1.00 LMNA (0.50) LMNAAPOBEC3AAPOBEC3GKMT2AGNAI3
SCHEMBL372390 1.00 LMNA (0.50) LMNAAPOBEC3AAPOBEC3GKMT2AGNAI3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 70 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3636638-A1 COMPOSITION COMPRISING AN IONIC LIQUID WITH FLUORINATED ANION proionic GmbH (AT) 2020-04-15 EP claimed
US-20260121095-A1 Advanced Ion Exchange Membranes And Applications Thereof WILLIAMS RICHARD KENT (US) 2026-04-30 US disclosed
EP-4621033-A1 ANTI-WEAR AGENT Idemitsu Kosan Co.,Ltd. (JP) 2025-09-24 EP disclosed
EP-4269396-B1 COMPOUND, CORROSION INHIBITOR, AND LUBRICANT COMPOSITION IDEMITSU KOSAN CO (JP) 2025-05-14 EP disclosed
US-11996557-B2 Direct regeneration of lithium ion cathodes by ionothermal relithiation UT-BATTELLE, LLC (US) 2024-05-28 US disclosed
WO-2024106393-A1 ANTI-WEAR AGENT 出光興産株式会社 2024-05-23 WO disclosed
CN-111849369-B Surface protective film and optical member 日东电工株式会社 2024-04-26 CN disclosed
US-20240124407-A1 COMPOUND, CORROSION INHIBITOR, AND LUBRICANT COMPOSITION IDEMITSU KOSAN CO.,LTD. (JP) 2024-04-18 US disclosed
CN-113382860-B Adhesive sheet and use thereof 日东电工株式会社 2024-03-22 CN disclosed
EP-4269396-A1 COMPOUND, CORROSION INHIBITOR, AND LUBRICANT COMPOSITION Idemitsu Kosan Co., Ltd. (JP) 2023-11-01 EP disclosed
US-20120202055-A1 PRESSURE-SENSITIVE ADHESIVE SHEET AND SURFACE PROTECTIVE FILM NITTO DENKO CORPORATION (JP) 2012-08-09 US disclosed
EP-2484734-A2 Pressure-sensitive adhesive sheet and surface protective film Nitto Denko Corporation (JP) 2012-08-08 EP disclosed
EP-1939263-B1 ADHESIVE COMPOSITION, ADHESIVE SHEET, AND SURFACE PROTECTIVE FILM NITTO DENKO CORP (JP) 2012-08-01 EP disclosed
US-20120175266-A1 METHOD FOR SYNTHESIS OF TITANIUM DIOXIDE NANOTUBES USING IONIC LIQUIDS UT-BATTELLE, LLC (US) 2012-07-12 US disclosed
EP-2410601-A1 IONIC LIQUID, ELECTROLYTE, LITHIUM SECONDARY BATTERY COMPRISING SAME, AND PROCESS FOR PRODUCING IONIC LIQUID The Nippon Synthetic Chemical Industry Co., Ltd. (JP) 2012-01-25 EP disclosed
US-20110311865-A1 IONIC LIQUID, ELECTROLYTE, LITHIUM SECONDARY BATTERY USING THE SAME, AND PROCESS FOR PRODUCING IONIC LIQUID THE NIPPON SYNTHETIC CHEMICAL INDUSTRY CO., LTD. (JP) 2011-12-22 US disclosed
US-20100311615-A1 METHOD FOR SYNTHESIS OF TITANIUM DIOXIDE NANOTUBES USING IONIC LIQUIDS UT-BATTELLE, LLC (US) 2010-12-09 US disclosed
US-7799853-B2 Adhesive composition, adhesive sheet, and surface protective film NITTO DENKO CORPORATION (JP) 2010-09-21 US disclosed
US-20090163626-A1 ADHESIVE COMPOSITION, ADHESIVE SHEET, AND SURFACE PROTECTIVE FILM NITTO DENKO CORPORATION (JP) 2009-06-25 US disclosed
EP-1939263-A1 ADHESIVE COMPOSITION, ADHESIVE SHEET, AND SURFACE PROTECTIVE FILM Nitto Denko Corporation (JP) 2008-07-02 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260121095-A1 Advanced Ion Exchange Membranes And Applications Thereof MYOC, MB, MYOF LMNA 32/4885APOBEC3A 4145/4885APOBEC3G 3738/4885
US-20240124407-A1 COMPOUND, CORROSION INHIBITOR, AND LUBRICANT COMPOSITION RB1, F12, CDKN1A LMNA 4267/4885APOBEC3A 3879/4885APOBEC3G 3912/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.